The key players profiled in the global atherectomy devices market include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Cardiovascular Systems, Inc. (CSI), Koninklijke Philips N.V., Terumo Corporation, Avinger, Inc., AngioDynamics Inc., Becton, Dickinson and Company (BD), Cardinal Health Inc., Straub Medical AG, Rex Medical LP, Biotronik SE & Co. KG, Nipro Corporation, and Biomerics LLC.